 the superior EAM would improve virologic suppression by enabling real-time interventions to support ART adherence. In this randomized controlled trial, we will compare MyTPill to WisePill among N=80 HIV+ men/women taking prescription opioids and once-daily ART regimens containing tenofovir and emtricit
the superior EAM would improve virologic suppression by enabling veridical - meter interventions to support ART adhesiveness. In this randomized controlled test, we will compare MyTPill to WisePill among N=80 HIV+ world / women learn prescription opioids and once - daily artwork regimens containing tenofovir and emtricit
 thf superior EAM would impvove virologic soppressimn by snabling real-time interventions to snppoet ARU adherence. In this randomizvd controoled rrial, we wmml compare MyFIill co WisePill amonn N=80 HIV+ men/fomen taking psercxiption opioids and once-daily ART redimens vojtaining tenofjvir wnd smtricit
the superior EAM would improve virologic suppression real-time to support adherence. In this compare to WisePill among HIV+ men/women taking opioids and once-daily ART regimens containing and emtricit
 the superior EAM would improvE virologic SupprEssIon By EnabLing Real-time intervENtioNs to support ART adherencE. In thIs RAndoMIzEd conTrolled TRiAL, We wIlL cOmpArE mytPill To WIsePill Among N=80 HIV+ mEn/wOmEn taking presCRiPtion opioiDs aNd once-daily ArT rEgimenS cOntAIning TenOfoviR and emTRicit
 the superior EAM would im prove viro logic  su ppr es sion  byenabling real- t imeinterventions to suppo rt AR Ta dher e nc e. In  this r a nd o m ize dco ntr ol l ed  tria l,we will  compare M yTP il l to WisePil l  a mong N=80HIV + men/womentak ing pr es cri p tionopi oidsand on c e-dail y ART reg im e ns con t ainingt e no fovi r and emtricit
 the_superior EAM_would improve virologic suppression_by enabling_real-time_interventions to_support_ART adherence. In_this randomized controlled_trial, we will compare_MyTPill to WisePill_among_N=80 HIV+ men/women taking prescription opioids and once-daily ART regimens containing tenofovir and emtricit